Lidovara
PrescriptionNomes comerciais: Lidovara
About This Medication
DESCRIPTION Lidovara™ is a topical gel containing Lidocaine Hydrochloride 28 mg/g (2.8%).
Princípios Ativos
| Ingrediente | Concentração |
|---|---|
| Lidocaine | - |
Indicações e Uso
Posologia e Administração
Advertências e Precauções
WARNINGS For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.
Contraindicações
CONTRAINDICATIONS Lidovara™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
Frequently Asked Questions
INDICATIONS AND USAGE Lidovara™ is indicated for topical analgesia as directed by a healthcare provider.
DOSAGE AND ADMINISTRATION For topical use only. Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.
WARNINGS For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.
CONTRAINDICATIONS Lidovara™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
Lidovara is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — Lidovara drug label (National Library of Medicine)
- • openFDA — Lidovara label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 2562183 (NLM Normalized Drug Names)
- • NDC Directory — Lidovara (FDA National Drug Code)
Aviso Médico
As informações nesta página têm fins exclusivamente educacionais e não devem ser usadas como substituto para aconselhamento médico profissional, diagnóstico ou tratamento.
Sempre busque o aconselhamento do seu médico ou outro profissional de saúde qualificado para quaisquer dúvidas que você possa ter sobre uma condição médica ou medicamento.
Fontes de dados: DailyMed (NLM), openFDA, MFDS